| (AUD) | Jun 2025 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | -100.00% |
| Operating expense | — | — |
| Net income | -18.77M | -68.00% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, PAR.AX returned -35.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -41.2% |
| 1 year | -35.5% |
| 5 years | -89.5% |
| 10 years | -50.7% |
| All-time high | $4.06 (Dec 2019) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in PAR.AX would be worth today ›No. Paradigm Biopharmaceuticals Limited has not paid a dividend in the past 12 months.
Paradigm Biopharmaceuticals Limited is part of the Healthcare sector.
Paradigm Biopharmaceuticals Limited has a market cap of 119.84M AUD, based on the latest quote.
